Phototherapy developer CyDen gets funding from Unilever, adoption by Spa & Salon

May 12, 2008 -- CyDen Ltd., a medical devices company and pioneer of intense pulsed light (IPL) technology based in Swansea, Wales, says it has received a significant capital investment from Unilever Ventures.

According to CyDen, its iPulse products -- which offer light-based treatments for permanent hair reduction, acne, skin blemishes, pigmentation as well as phototherapy for anti-aging and wrinkle reduction -- are poised for significant growth following the successful completion of a Series C investment round. The round attracted Unilever Ventures, a new investor, as part of a £2.8 million investment round managed by Longbow Capital LLP.

CyDen is now ideally placed to leverage its innovative technology and competitive pricing to capture an increasing share of the rapidly growing medical aesthetics market worldwide.

CyDen also reports that Spa and Salon International (SSI), which is backed by Unilever Ventures, has selected iPulse for installation in its ReAqua, Ponds Institute, and Dove Spa branded salons following an intensive trial period in Dove Spa. SSI selected iPulse for its expanding network of spas and salons across Europe and the Americas in order to offer in-house hair removal and skin treatments.

CyDen has miniaturized and simplified the power technology to provide small and portable IPL devices that deliver safe and effective results at lower energy levels than other forms of treatment for exciting new treatment possibilities.

Professor Marc Clement, Chairman of CyDen, said, "We are delighted that Unilever Ventures recognizes both the immediate and future impact of CyDen in the professional and spa environment. Light therapy offers a tremendous opportunity for non-invasive cosmetic treatments and an alternative to traditional skin care remedies. With the backing from investors such as Unilever Ventures we look forward to building strategic partnerships to strengthen our business and ultimately enable expansion into new markets."

The investment from Unilever Ventures, the venture capital firm fully backed by Unilever Plc, marks a significant development for both organizations. In addition to the financial support, CyDen will benefit from the presence of Unilever Ventures on its Board of Directors.

CyDen says its iPulse technology marks a major new development in IPL therapy. Ongoing clinical education for users, along with the upcoming "iPulse experience" customer care program, promises business owners a reliable and cost-effective entry into today's lucrative aesthetic and beauty market. CyDen operates a growing distribution network with representation in more than 50 countries.

The investment from Unilever Ventures, builds on the support CyDen receives from Longbow Capital LLP, an investor and strategic partner since 2004. Longbow, a specialist venture capital firm, provides capital and management support to consumer facing and technology-based businesses. It is focused on making investments into new and innovative companies that can potentially grow into very meaningful businesses to address a global demand.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

(SLIDESHOW) View the July/August 2013 issue

Low-intensity red laser light boosts teeth whitening

A study conducted by researchers from São Paulo State University confirms that using low-level red laser light to activate bleaching gel increases the effectiveness of teeth whitening.

NONINVASIVE BIOIMAGING: NIR-based vascular imaging device wins excellence award

Christie Medical Innovations' (Memphis, TN) vascular imaging system, VeinViewer Vision, has been recognized as a winner for the 2011 Medical Design Excellence Award (MDEA).

Optical coherence tomography aids photodynamic therapy in skin cancer treatment

Researchers have documented successful use of Michelson Diagnostics' VivoSight optical coherence tomography (OCT) scanner for in-vivo mapping of non-melanoma skin cancer, which they used throughout...

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS